In line with this, ROCK1 has attracted significant interest as a potential target for the treatment of a wide range of pathological conditions including cancer, neuronal degeneration, kidney failure, asthma, glaucoma, osteoporosis, erectile dysfunction, insulin resistance and its cardiovascular complications [37]. This evidence concerns the gene ROCK1 and erectile dysfunction.